Rubric Capital Management (New York)’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.5M | Hold |
15,307,347
| – | – | 0.63% | 36 |
|
|
2025
Q1 | $34.4M | Hold |
15,307,347
| – | – | 0.62% | 37 |
|
|
2024
Q4 | $53.6M | Hold |
15,307,347
| – | – | 0.69% | 28 |
|
|
2024
Q3 | $62.9M | Hold |
15,307,347
| – | – | 1.03% | 25 |
|
|
2024
Q2 | $55.1M | Buy |
15,307,347
+1,754,350
| +13% | +$6.32M | 1.44% | 28 |
|
|
2024
Q1 | $44.7M | Hold |
13,552,997
| – | – | 1.32% | 27 |
|
|
2023
Q4 | $31.3M | Buy |
13,552,997
+1,936,877
| +17% | +$4.47M | 0.65% | 32 |
|
|
2023
Q3 | $15M | Hold |
11,616,120
| – | – | 0.56% | 39 |
|
|
2023
Q2 | $15.3M | Buy |
11,616,120
+1,250,000
| +12% | +$1.65M | 0.66% | 40 |
|
|
2023
Q1 | $7.33M | Hold |
10,366,120
| – | – | 0.19% | 58 |
|
|
2022
Q4 | $7.77M | Hold |
10,366,120
| – | – | 0.34% | 61 |
|
|
2022
Q3 | $8.93M | Sell |
10,366,120
-6,390,000
| -38% | -$5.5M | 0.45% | 48 |
|
|
2022
Q2 | $18.8M | Buy |
16,756,120
+1,756,120
| +12% | +$1.97M | 0.99% | 32 |
|
|
2022
Q1 | $16.8M | Buy |
15,000,000
+85,553
| +0.6% | +$95.8K | 0.61% | 38 |
|
|
2021
Q4 | $23.9M | Buy |
14,914,447
+3,614,447
| +32% | +$5.78M | 1.13% | 31 |
|
|
2021
Q3 | $27.3M | Buy |
11,300,000
+5,639,392
| +100% | +$13.6M | 0.76% | 28 |
|
|
2021
Q2 | $17.9M | Buy |
5,660,608
+2,745,747
| +94% | +$8.7M | 1.13% | 37 |
|
|
2021
Q1 | $9.82M | Buy |
2,914,861
+1,061,444
| +57% | +$3.58M | 0.57% | 46 |
|
|
2020
Q4 | $6.64M | Buy |
+1,853,417
| New | +$6.63M | 0.49% | 45 |
|